Outcomes of Pediatric HIV Treatment in South Africa
Author Information
Author(s): Reddi Anand, Leeper Sarah C, Grobler Anneke C, Geddes Rosemary, France K Holly, Dorse Gillian L, Vlok Willem J, Mntambo Mbali, Thomas Monty, Nixon Kristy, Holst Helga L, Karim Quarraisha Abdool, Rollins Nigel C, Coovadia Hoosen M, Giddy Janet
Primary Institution: Sinikithemba HIV/AIDS Clinic, McCord Hospital, Durban, South Africa
Hypothesis
Can pediatric highly active antiretroviral therapy (HAART) be effective in resource-limited settings in Africa?
Conclusion
The study suggests that pediatric HAART can be effective despite the challenges of a resource-limited setting.
Supporting Evidence
- 151 children initiated HAART during the study period.
- 84% of children had undetectable viral loads at 6 months.
- 73.8% of children reported significant weight gain after the first month.
- The one-year survival estimate was 90.9%.
Takeaway
This study shows that children with HIV in South Africa can get better with treatment, even when there are not many resources available.
Methodology
A retrospective cohort study analyzing immunologic, virologic, clinical, and psychosocial variables of children eligible for HAART.
Potential Biases
Potential bias due to the self-reported ability of caregivers to fund treatment.
Limitations
The self-pay requirement may have led to selection bias towards patients with greater financial resources.
Participant Demographics
The cohort included 151 children, median age 5.7 years, with a majority having advanced HIV disease.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 84.8–94.6
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website